![Craig C. Estwick](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Craig C. Estwick
Voorzitter bij Nexpep Pty Ltd.
Actieve functies van Craig C. Estwick
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Nexpep Pty Ltd. | Voorzitter | 01-01-2009 | - |
Loopbaan van Craig C. Estwick
Eerdere bekende functies van Craig C. Estwick
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Deloitte Consulting Pty Ltd.
![]() Deloitte Consulting Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Deloitte Consulting Pty Ltd. provides cyber security consulting services. The company is based in Sydney, Australia. | Corporate Officer/Principal | - | 01-01-2000 |
ImmusanT, Inc.
![]() ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Directeur/Bestuurslid | - | - |
Opleiding van Craig C. Estwick
The University of Queensland | Graduate Degree |
Statistieken
Internationaal
Australië | 4 |
Verenigde Staten | 2 |
Operationeel
Director/Board Member | 1 |
Graduate Degree | 1 |
Chairman | 1 |
Sectoraal
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
ImmusanT, Inc.
![]() ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Health Technology |
Nexpep Pty Ltd. | |
Deloitte Consulting Pty Ltd.
![]() Deloitte Consulting Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Deloitte LLP (New York), Deloitte Consulting Pty Ltd. provides cyber security consulting services. The company is based in Sydney, Australia. | Commercial Services |
- Beurs
- Insiders
- Craig C. Estwick
- Ervaring